Skip left side navigation and go to content

NHLBI leadership journal connecting you to the leaders of tomorrows science today

Welcome to the Leadership Journal

Under the American Recovery and Reinvestment Act (ARRA), the NHLBI will invest approximately $763 million in scientific research on the prevention and treatment of heart, lung, and blood diseases—diseases that include three of the four leading causes of death in the United States. This investment is already helping to save or create jobs at research centers across the country.
 
The Leadership Journal is a forum for the NHLBI’s senior leadership team to join me in bringing you our thoughts and perspectives on the people and projects supported by this unprecedented scientific effort. We'll discuss everything from planning and grant distribution to ARRA's economic and scientific impact.
 
Susan B. Shurin, M.D.
Acting Director of the National Heart, Lung, and Blood Institute (NHLBI)


Setting a Healthy Example at Home for Adolescents
By: Dr. Elizabeth Nabel, NHLBI Posted: October 13, 2009

I had the pleasure of joining NHLBI grantee Dianne Neumark-Sztainer, Ph.D., on a health and wellness panel at CNNís Fit Nation tour in St. Paul, Minn., last weekend.

Read More >>

A Presidential Visit
By: Dr. Elizabeth Nabel, NHLBI Posted: September 30, 2009

President Obama and Secretary Sebelius traveled to the NIH today to announce the unprecedented $5 billion that has so far been allocated to biomedical research through the American Recovery and Reinvestment Act. In his speech, the President singled out heart disease as an area that will benefit from an intense, stimulus-funded research focus.

Read More >>

The Recovery Act and Comparative Effectiveness Research
By: Dr. Michael Lauer, NHLBI Posted: September 30, 2009

In the American Recovery and Reinvestment Act of 2009 (ARRA), Congress appropriated $1.1 billion for comparative effectiveness research, or CER, with $400 million allocated to the NIH.  To help ensure that the government aligns its priorities with national needs, the legislation created a Federal Coordinating Council (FCC) of senior federal officials who were charged to inventory and articulate major gaps in federal CER efforts.  The FCC was also asked to make recommendations to the Secretary of HHS about how best to spend the Department’s $400 million allocation. 

Read More >>

NHLBI Recognizes Star Award Recipients
By: Dr. Elizabeth Nabel, NHLBI Posted: September 15, 2009

Last week the NHLBI leadership team recognized numerous members of the NHLBI staff for the key role they played in maximizing the investment in science through the American Recovery and Reinvestment Act of 2009 (ARRA). Their hard work spent managing and tracking grant applications, coordinating peer review meetings, providing scientific program support, and developing information technology tools, was deserving merit.

Read More >>

Priorities for Comparative Effectiveness Research
By: Dr. Michael Lauer, NHLBI Posted: September 9, 2009

Perhaps no single health-related component of the American Recovery and Reinvestment Act of 2009 has received more attention than the $1.1 billion appropriation for comparative effectiveness research, or CER.  CER is a type of clinical or public health research that directly informs clinical practice or public policy.  Specifically, CER involves real-world comparisons of different existing strategies for prevention, treatment, or management of disease.  Even before the American Recovery and Reinvestment Act of 2009 , the NHLBI has had a long and proud...

Read More >>

The Recovery Act and the NHLBI: A Team Effort
By: Dr. Elizabeth Nabel, NHLBI Posted: September 4, 2009

I would like to kick off the Leadership Journal by thanking those of you who are working so hard to make the NHLBIís participation in the American Recovery and Reinvestment Act of 2009 a success. From the NIH/NHLBI staff to our extramural research community, we are working together to ensure that this investment helps us expand our research in the prevention and treatment of heart, lung, and blood diseases while stimulating the U.S. economy through biomedical research at our nationís institutions.

Read More >>


Last Updated: January 8, 2010

meet the authors

suggest a topic



Leadership Journal Archive
September 2009






Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon